A nomogram based on LI-RADS features, clinical indicators and quantitative contrast-enhanced MRI parameters for predicting glypican-3 expression in hepatocellular carcinoma

A nomogram based on LI-RADS features, clinical indicators and quantitative contrast-enhanced MRI parameters for predicting glypican-3 expression in hepatocellular carcinoma

PurposeNoninvasively assessing the tumor biology and microenvironment before treatment is greatly important, and glypican-3 (GPC-3) is a new-generation immunotherapy target for hepatocellular carcinoma (HCC). This study investigated the application value of a nomogram based on LI-RADS features, quan...

Full description

Bibliographic Details
Main Authors: Yan Song, Yue-yue Zhang, Qin Yu, Tong Chen, Chao-gang Wei, Rui Zhang, Wei Hu, Xu-jun Qian, Zhi Zhu, Xue-wu Zhang, Jun-kang Shen
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Oncology
Subjects:
hepatocellular carcinoma
glypican-3
immunotherapy
LI-RADS
Gd-EOB-DTPA
nomogram
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1123141/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1123141/full

Similar Items